Pascal Deschatelets
Founder at APELLIS PHARMACEUTICALS, INC.
Net worth: 66 M $ as of 31/03/2024
Profile
Pascal Deschatelets is an entrepreneur who founded Apellis Pharmaceuticals, Inc., Potentia Pharmaceuticals, Inc., Revon Systems, Inc. and Syntetica Fine Chemicals. Presently, he holds the position of Chief Scientific Officer at Apellis Pharmaceuticals, Inc. He is also on the board of Revon Systems, Inc. Pascal Deschatelets previously held the position of Chief Operating Officer for Potentia Pharmaceuticals, Inc. He received a doctorate from the University of Montréal.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/04/2024 | 1,115,983 ( 0.93% ) | 66 M $ | 31/03/2024 |
Pascal Deschatelets active positions
| Companies | Position | Start |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Founder | 25/09/2009 |
Revon Systems, Inc.
 Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Founder | - |
Former positions of Pascal Deschatelets
| Companies | Position | End |
|---|---|---|
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Founder | 01/09/2016 |
| Syntetica Fine Chemicals | Founder | - |
Training of Pascal Deschatelets
| University of Montréal | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Revon Systems, Inc.
Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Technology Services |
| Syntetica Fine Chemicals |
- Stock Market
- Insiders
- Pascal Deschatelets
